284 related articles for article (PubMed ID: 25617027)
1. Microengineered liver tissues for drug testing.
Khetani SR; Berger DR; Ballinger KR; Davidson MD; Lin C; Ware BR
J Lab Autom; 2015 Jun; 20(3):216-50. PubMed ID: 25617027
[TBL] [Abstract][Full Text] [Related]
2. The application of engineered liver tissues for novel drug discovery.
Lin C; Ballinger KR; Khetani SR
Expert Opin Drug Discov; 2015 May; 10(5):519-40. PubMed ID: 25840592
[TBL] [Abstract][Full Text] [Related]
3. Engineered Liver Platforms for Different Phases of Drug Development.
Ware BR; Khetani SR
Trends Biotechnol; 2017 Feb; 35(2):172-183. PubMed ID: 27592803
[TBL] [Abstract][Full Text] [Related]
4. Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury.
Lin C; Khetani SR
Biomed Res Int; 2016; 2016():1829148. PubMed ID: 27725933
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
Ware BR; Berger DR; Khetani SR
Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
[TBL] [Abstract][Full Text] [Related]
6. Stem cell-derived liver cells for drug testing and disease modeling.
Davidson MD; Ware BR; Khetani SR
Discov Med; 2015 May; 19(106):349-58. PubMed ID: 26105698
[TBL] [Abstract][Full Text] [Related]
7. Current limitations and future opportunities for prediction of DILI from in vitro.
Funk C; Roth A
Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
[TBL] [Abstract][Full Text] [Related]
8. A Bioprinted Liver-on-a-Chip for Drug Screening Applications.
Knowlton S; Tasoglu S
Trends Biotechnol; 2016 Sep; 34(9):681-682. PubMed ID: 27291461
[TBL] [Abstract][Full Text] [Related]
9. Judging the value of 'liver-on-a-chip' devices for prediction of toxicity.
Starokozhko V; Groothuis GM
Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):125-128. PubMed ID: 27724053
[No Abstract] [Full Text] [Related]
10. Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety.
Meseguer-Ripolles J; Khetani SR; Blanco JG; Iredale M; Hay DC
AAPS J; 2017 Dec; 20(1):20. PubMed ID: 29270863
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening.
Nam KH; Smith AS; Lone S; Kwon S; Kim DH
J Lab Autom; 2015 Jun; 20(3):201-15. PubMed ID: 25385716
[TBL] [Abstract][Full Text] [Related]
12. Biomimetic cardiac microsystems for pathophysiological studies and drug screens.
Lee J; Razu ME; Wang X; Lacerda C; Kim JJ
J Lab Autom; 2015 Apr; 20(2):96-106. PubMed ID: 25524490
[TBL] [Abstract][Full Text] [Related]
13. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model.
Chang R; Emami K; Wu H; Sun W
Biofabrication; 2010 Dec; 2(4):045004. PubMed ID: 21079286
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced liver injury and drug development: industry perspective.
Regev A
Semin Liver Dis; 2014 May; 34(2):227-39. PubMed ID: 24879986
[TBL] [Abstract][Full Text] [Related]
15. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
Watson DE; Hunziker R; Wikswo JP
Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
[TBL] [Abstract][Full Text] [Related]
16. Human induced pluripotent stem cell-derived hepatocytes for toxicology testing.
Mann DA
Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):1-5. PubMed ID: 25385341
[TBL] [Abstract][Full Text] [Related]
17. Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans.
Atienzar FA; Novik EI; Gerets HH; Parekh A; Delatour C; Cardenas A; MacDonald J; Yarmush ML; Dhalluin S
Toxicol Appl Pharmacol; 2014 Feb; 275(1):44-61. PubMed ID: 24333257
[TBL] [Abstract][Full Text] [Related]
18. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro.
Jiang J; Pieterman CD; Ertaylan G; Peeters RLM; de Kok TMCM
Arch Toxicol; 2019 Nov; 93(11):3067-3098. PubMed ID: 31586243
[TBL] [Abstract][Full Text] [Related]
19. The Discovery Channel: microfluidics and microengineered systems in drug screening.
Moraes C
Integr Biol (Camb); 2015 Mar; 7(3):285-8. PubMed ID: 25677245
[TBL] [Abstract][Full Text] [Related]
20. An integrated biomimetic array chip for establishment of collagen-based 3D primary human hepatocyte model for prediction of clinical drug-induced liver injury.
Xiao RR; Lv T; Tu X; Li P; Wang T; Dong H; Tu P; Ai X
Biotechnol Bioeng; 2021 Dec; 118(12):4687-4698. PubMed ID: 34478150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
